Atyr Pharma WKN: A2PM86 ISIN: US0021202025 Forum: Aktien User: Spottford

Stocktwits trending und reddit bisschen unterwegs. ATYR has the highest implied volatility of any stock in the entire market right now. Read that again. Options pricing shows the market expects a move of 700% BY FRIDAY OF NEXT WEEK. Why? Phase 3 data for the drug Efzofitimod is expected to be released early next week. For the first time in 70 years, this drug could change how doctors treat sarcoidosis and interstitial lung disease. Rare disease, orphan drug, FDA loves the study endpoint. The tailwinds here are strong. On good data, analysts at Wells Fargo place the stock’s fair market value at 5-11x the current prices. If that data hits, the price rerate happens overnight. But there’s more. There’s a committed group of short investors being led by none other than Martin Shkreli. Yes, the same guy who just got his followers to go short on $OPEN. Oopsy. The short squeeze on $ATYR could be massive, and it may take them by surprise. They seem to be only seeing that shorts hold a moderate 29% of shares. Should be easy to unwind, right? But look at the rest of the ownership structure. 70% of shares are held by institutions. A lot of that is locked up in never-sell index tracking ETFs. The rest know what they’re holding, they’re pros and they will be patient. 10-12% of shares are held by high-conviction retail investors who are unusually well educated via the countrydumb and atyr_alpha subs. They also know what they’re holding. And then there’s 3% reported insider ownership. None of these holders will be rushing to save the shorts by selling low. So shorts are likely to get trapped and desperate, offering higher and higher prices as their lenders demand share repayments. How high could this go? We don’t know. But it could very well be just as memorable as $GME. Sure, for the size of the squeeze, but also for the broad base of retail participation. You could see a whole bunch of blue collar investors and redditors becoming sudden millionaires. But this time, they’ll be working together with the institutions. Pretty wild. So what are the odds? The brightest scientific minds, KOLs, and analysts put the likelihood of positive trial data at 65-85%. Those are insane odds for a 5x return. But this is still risky. There’s a 15-35% that your $1,000 investment could drop to $200 overnight. And no, a stop loss won’t save you, since data will be released outside of market hours. If you’re thinking about getting in, be honest with yourself about the risk. I currently own 120,000 shares ($700k) down from 161,000 shares. I recently took a little profit to cover my ass, so I’m riding into this binary on (mostly) casino money. What I’m saying is, don’t be a degen. But if you’ve got some gambling money laying around, give it a look. It’s the most asymmetric bet I’ve ever seen ahead of time.

Hoffentlich Insider

Decken sich wahrscheinlich ein vor den Topline Daten, vielleicht auch Insider.

Was einer was los ist?

👀

Möge die Party beginnen. Lasst die Shorts brennen🙌🙌🤩🤩🔥🔥

5x oder -50% mach demnächst kleine Positon rein

Topline Daten werden für Mitte September erwartet.

Wie stark seid ihr dort investiert?

Ich denke jeder der hier investiert ist, müsste wissen das es die Ergebnisse der Phase 3 Studie demnächst gibt. Wie sie ausfallen oder was darin steht, kann ja hier keiner erahnen. Die Aktie, das Unternehmen ist ein Hochrisikoinvest, kann alles passieren.

Was denkt ihr darüber, wann die Studie veröffentlicht wird und ob sie positive Ergebnisse haben wird?Habt ihr schon etwas darüber gehört?.

Ufff jetzt mache ich mir sorgen mit der Aktie

Meine Vermutung, die schwachen Hände werden aus der Aktie gedrängt, die Stop Losses abgefischt. Die Aktie hat in 2 Jahren fast 200 Prozent gemacht. Denke das ist ganz normal bei Biotech.

Was passiert hier?

Warum fällt der Aktienkurs schon wieder?.

Nix mit Verkaufen. Da fehlen noch ca.15-20 Dollar zur Zielmarke.Ruhig Blut und nicht nervös zucken.